Showing results (321-330 of 626) with videos related to

Sort By:
Pageof 63
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 31, 2001
Changes in bone density in patients with ankylosing spondylitis: a two-year follow-up studyJ F Maillefert, L S Aho, A El Maghraoui, et al.
Annals of the Rheumatic Diseases|March 17, 2006
A long-term, open-label trial of the safety and efficacy of etanercept (Enbrel) in patients with rheumatoid arthritis not treated with other disease-modifying antirheumatic drugsL Klareskog, M Gaubitz, V Rodriguez-Valverde, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 3, 2002
Prevention of early postmenopausal bone loss by strontium ranelate: the randomized, two-year, double-masked, dose-ranging, placebo-controlled PREVOS trialJ Y Reginster, R Deroisy, M Dougados, et al.
Dermatology (Basel, Switzerland)|April 11, 2012
Factors associated with severe skin infections in patients treated with biologic therapies for inflammatory rheumatic diseasesE Régnier-Rosencher, D Farhi, A Lebrun, et al.
The Journal of Rheumatology|October 21, 1999
Osteoporosis, body composition, and bone turnover in ankylosing spondylitisA El Maghraoui, D Borderie, B Cherruau, et al.
Clinical and Experimental Immunology|July 1, 1995
Neutrophil expression of tumour necrosis factor receptors (TNF-R) and of activation markers (CD11b, CD43, CD63) in rheumatoid arthritisS Lopez, L Halbwachs-Mecarelli, P Ravaud, et al.
Annals of the Rheumatic Diseases|August 28, 2004
Evaluation of the symptomatic and structural efficacy of a new hyaluronic acid compound, NRD101, in comparison with diacerein and placebo in a 1 year randomised controlled study in symptomatic knee osteoarthritisT Pham, A Le Henanff, Ph Ravaud, et al.
Clinical Biochemistry|December 12, 2001
Variability in urinary excretion of bone resorption markers: limitations of a single determination in clinical practiceD Borderie, C Roux, B Toussaint, et al.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|May 1, 1977
[Hydroxyapatite rheumatism (multiple tendon calcification disease). II. - Microscopic study - HL-A antigen - Experimental arthritis - Pathogeny]B Amor, A Kahan, A Cherot, et al.
Revue Du Rhumatisme (English Ed.)|March 1, 1995
Adult-onset idiopathic phosphate diabetes. I. Chronic pseudoinflammatory back pain and osteopeniaB Amor, P J Clemente-Coelho, G Rajzbaum, et al.
Pageof 63